Evidence map›Paper›PMID 26981166›Full record

ArticleOxidative medicine and cellular longevity2016

Polyethylene Glycol Preconditioning: An Effective Strategy to Prevent Liver Ischemia Reperfusion Injury.

Mohamed Bejaoui, Eirini Pantazi, Maria Calvo, Emma Folch-Puy, Anna Serafín, Gianfranco Pasut, Arnau Panisello, René Adam, Joan Roselló-Catafau

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Institut Georges Lopez-2M as a Novel Lung Preservation Solution Attenuates Ischemia-Reperfusion Injury in a RatTransplant international : official journal of the European Society for Organ Transplantation · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. PEG35 as a Preconditioning Agent against Hypoxia/Reoxygenation Injury.International journal of molecular sciences · 2022
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Mohamed BejaouiExperimental Pathology Department, Institute of Biomedical Research of Barcelona (IIBB), CSIC, Rossello 161, Barcelona, 08036 Catalonia, Spain.ORCID 0000-0003-1075-6170
Eirini PantaziExperimental Pathology Department, Institute of Biomedical Research of Barcelona (IIBB), CSIC, Rossello 161, Barcelona, 08036 Catalonia, Spain.
Maria CalvoAdvanced Optical Microscopy Unit CCiTUB, Science and Technology Center, Faculty of Medicine, University of Barcelona, C/Casanova 143, Barcelona, 08036 Catalonia, Spain.
Emma Folch-PuyExperimental Pathology Department, Institute of Biomedical Research of Barcelona (IIBB), CSIC, Rossello 161, Barcelona, 08036 Catalonia, Spain.
Anna SerafínPlatform of Laboratory Animal Applied Research, Barcelona Science Park, Barcelona, 08028 Catalonia, Spain.
Gianfranco PasutPharmaceutical and Pharmacological Sciences Department, University of Padova, 35131 Padova, Italy; Veneto Institute of Oncology (IOV), IRCCS, 35128 Padova, Italy.ORCID 0000-0002-8754-0899
Arnau PaniselloExperimental Pathology Department, Institute of Biomedical Research of Barcelona (IIBB), CSIC, Rossello 161, Barcelona, 08036 Catalonia, Spain.
René AdamHepato-Biliary Centre, Paul Brousse Hospital, Inserm U776, Paris-Sud University, Villejuif, 75008 Paris, France.
Joan Roselló-CatafauExperimental Pathology Department, Institute of Biomedical Research of Barcelona (IIBB), CSIC, Rossello 161, Barcelona, 08036 Catalonia, Spain.
Institut d'Investigacions Biomèdiques de Barcelona · ESBarcelona Biomedical Research Park · ESUniversitat de Barcelona · ESUniversité Paris-Sud · FRUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatic ischemia reperfusion injury (IRI) is an inevitable clinical problem for liver surgery. Polyethylene glycols (PEGs) are water soluble nontoxic polymers that have proven their effectiveness in various in vivo and in vitro models of tissue injury. The present study aims to investigate whether the intravenous administration of a high molecular weight PEG of 35 kDa (PEG 35) could be an effective strategy for rat liver preconditioning against IRI. PEG 35 was intravenously administered at 2 and 10 mg/kg to male Sprague Dawley rats. Then, rats were subjected to one hour of partial ischemia (70%) followed by two hours of reperfusion. The results demonstrated that PEG 35 injected intravenously at 10 mg/kg protected efficiently rat liver against the deleterious effects of IRI. This was evidenced by the significant decrease in transaminases levels and the better preservation of mitochondrial membrane polarization. Also, PEG 35 preserved hepatocyte morphology as reflected by an increased F-actin/G-actin ratio and confocal microscopy findings. In addition, PEG 35 protective mechanisms were correlated with the activation of the prosurvival kinase Akt and the cytoprotective factor AMPK and the inhibition of apoptosis. Thus, PEG may become a suitable agent to attempt pharmacological preconditioning against hepatic IRI.

Indexed as

AnimalsHepatocytesIschemic PreconditioningLiverLiver DiseasesMalePolyethylene GlycolsRatsRats, Sprague-DawleyReperfusion Injurypolyethylene glycol 1000Polyethylene Glycols

Identifiers

PMID26981166
PMCPMC4770158
OpenAlexW2258358312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.